October 6, 2022
It doesn’t get any better than this
In baseball we’ve got Yankees Red Sox – football Bears Packers – basketball Lakers Celtics and diabetes Lilly Novo Nordisk. These two are at again and the stakes have gotten even higher as Lilly is about to invade Novo’s turf as the FDA has fast tracked tirzepatide for obesity. So just as they have done with insulin Novo and Lilly are about to butt heads again in the expanding obesity market. Seriously it just doesn’t get any better than this.
This happens at the same time as Novo prepares to submit their once weekly insulin to the FDA. Iocdec . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
